Single-dose oral toxicity of fermented rice extracts [FREs]: a 14-day observation

ABSTRACT

The aim of present research was to determine the acute oral toxicity of fermented rice extracts [FREs], in female and male ICR mice. To investigate the toxicity and identify target organs, FREs were orally administered once to male and female ICR mice at doses of 0 [vehicle control], 500, 1000, or 2000 mg/kg body weight [BW]. Effects on mortality, BW, and clinical signs were monitored over 14 days, including changes in the weights and histopathological characteristics of 14 organs, as described in the Korea Food and Drug Administration [KFDA] Guidelines [2009-116, 2009]. No treatment-related mortality was observed during the 14-day observation period in either gender. In addition, no FRE-related change was observed in BW or organ weight [OW], clinical indicators, or histopathological findings in this study. Our results suggest that the FRE is non-toxic in mice and is therefore likely to be safe for clinical use. The approximate LD and LD[50] in mice after single oral dose of FRE are greater than 2000 mg/kg in female and male ICR mice. Additionally, no specific target organ or negative clinical indicator was detected in this study.